CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...

An advocacy group criticizes Hims & Hers Health for allegedly misleading Super Bowl ad promoting weight loss products, violating FDA regulations. Read more here.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

She's going to have good arms!' I was ten years old and standing in my parents' bathroom when I heard my mother say this.

Investors and analysts reacted immediately to Novo's revelation. The price of Novo's common stock declined dramatically. From ...

Response Pharmaceuticals, Inc., a clinical-stage company focused on weight management and metabolic health in high-risk populations, today announced the early completion of enrollment in a Phase 2 ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...